Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) shares gapped down prior to trading on Wednesday. The stock had previously closed at $4.08, but opened at $3.81. Anbio Biotechnology shares last traded at $3.97, with a volume of 1,856 shares changing hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, October 8th. One research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Anbio Biotechnology Stock Up 7.2%

The company’s fifty day moving average is $4.93 and its two-hundred day moving average is $16.27.

About Anbio Biotechnology

Anbio Biotechnology is a medical technology company focused on in vitro diagnostic products used to detect and monitor health conditions. Its offerings include diagnostic testing systems and related products designed for clinical and point-of-care settings. The company’s product portfolio includes testing equipment and diagnostic reagents, supporting the analysis of patient samples. These tools are intended to help healthcare providers obtain test results outside or alongside conventional laboratory workflows.